Market Cap 36.47M
Revenue (ttm) 140,000.00
Net Income (ttm) 9.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 6,478.57%
Debt to Equity Ratio 0.01
Volume 76,539,805
Avg Vol 20,269,240
Day's Range N/A - N/A
Shares Out 23.23M
Stochastic %K 52%
Beta 3.11
Analysts Strong Buy
Price Target N/A

Company Profile

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN...

Industry: Pharmaceutical Retailers
Sector: Healthcare
Phone: 800 261 0281
Address:
6308 Benjamin Rd, Suite 708, Tampa, United States
Oronero
Oronero Oct. 27 at 12:58 PM
$SCNX Essential lifesaving medicine...#huge
0 · Reply
ChasingGreenCandle
ChasingGreenCandle Oct. 27 at 12:57 PM
$SCNX from my estimats and quantitative data the market open for this stock it will be above $1.365
0 · Reply
Muhammad7
Muhammad7 Oct. 27 at 12:52 PM
$SCNX dumb drop
0 · Reply
bassett
bassett Oct. 27 at 12:49 PM
$SCNX (SCNX) Dead. $CODX I did rightnow 15% profit in 20second
0 · Reply
ChasingGreenCandle
ChasingGreenCandle Oct. 27 at 12:40 PM
$SCNX guys stop making bets and think and do your own research. The shorts don't know what they are shorting also. This company released a new product.(losartan) In a US Market there are $256 million annual prescriptions. This product is a need for the patients who cannot swallow tablets, such as children over six and elderly adults with dysphagia. This medication dies not require refrigeration and has a 24 months shelf life at room temperature. The stock drops because it was a share dilution and the shorts profited. The capital rise it was a must. You can check my previous post also. DO YOUR OWN DD AND STOP RELY ON OTHERS.
0 · Reply
bassett
bassett Oct. 27 at 12:32 PM
$SCNX (SCNX) Still red flag. RECT stock of the day i make 27% profit
0 · Reply
Watsonwestie
Watsonwestie Oct. 27 at 12:30 PM
$SCNX lol. See you at 2.00
0 · Reply
JackCampbell
JackCampbell Oct. 27 at 12:27 PM
$SCNX expect exclusive requests and agreements for the distribution of Arbli in other global regions anytime now. Scienture would receive a high upfront payment and percentage of net sales with beginning sales. Further collaborations will enable access to Arbli for patients wordwide in very short time period.
0 · Reply
ChasingGreenCandle
ChasingGreenCandle Oct. 27 at 12:23 PM
$SCNX guys I want to inform you about the following. The share dilution raport: 30/September 21.93 million shares 27/October 34.47 million shares The share dilution was completed. Curent Cash Estimate $14.35 million. So they have cash to operate normaly for a while. They released a new product and the cash will come soon to sustain the business.
1 · Reply
invbond
invbond Oct. 27 at 12:18 PM
$SCNX is holding up well and well above $0.50 level a few days ago. We will be back over to $2.0 again Keep an eye on $VIVK - Squeeze alert ( like SCNX) could pop it back to Friday's high of ~$0.50 and Squeeze it over to $1.X+ Has ~$250M in assets and just closed a $40M CF.
1 · Reply
Latest News on SCNX
Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding

Jul 24, 2025, 5:12 PM EDT - 3 months ago

Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding


Scienture Holdings Announces Cancelation of ELOC

Jun 17, 2025, 8:05 AM EDT - 4 months ago

Scienture Holdings Announces Cancelation of ELOC


SCIENTURE Announces Executive Leadership Transition

May 22, 2025, 8:05 AM EDT - 5 months ago

SCIENTURE Announces Executive Leadership Transition


Scienture Holdings, Inc. Issues Annual Letter to Shareholders

Apr 3, 2025, 8:26 AM EDT - 7 months ago

Scienture Holdings, Inc. Issues Annual Letter to Shareholders


TRxADE Health, Inc. Announces Special Cash Dividend

Jul 9, 2024, 8:05 AM EDT - 1 year ago

TRxADE Health, Inc. Announces Special Cash Dividend


Trxade health, Inc files its 3Q 10Q

Jan 17, 2024, 9:07 AM EST - 1 year ago

Trxade health, Inc files its 3Q 10Q


TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing

Aug 14, 2023, 10:25 AM EDT - 2 years ago

TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing


TRxADE HEALTH, Inc. (MEDS) Q1 2023 Earnings Call Transcript

May 15, 2023, 10:30 PM EDT - 2 years ago

TRxADE HEALTH, Inc. (MEDS) Q1 2023 Earnings Call Transcript


Oronero
Oronero Oct. 27 at 12:58 PM
$SCNX Essential lifesaving medicine...#huge
0 · Reply
ChasingGreenCandle
ChasingGreenCandle Oct. 27 at 12:57 PM
$SCNX from my estimats and quantitative data the market open for this stock it will be above $1.365
0 · Reply
Muhammad7
Muhammad7 Oct. 27 at 12:52 PM
$SCNX dumb drop
0 · Reply
bassett
bassett Oct. 27 at 12:49 PM
$SCNX (SCNX) Dead. $CODX I did rightnow 15% profit in 20second
0 · Reply
ChasingGreenCandle
ChasingGreenCandle Oct. 27 at 12:40 PM
$SCNX guys stop making bets and think and do your own research. The shorts don't know what they are shorting also. This company released a new product.(losartan) In a US Market there are $256 million annual prescriptions. This product is a need for the patients who cannot swallow tablets, such as children over six and elderly adults with dysphagia. This medication dies not require refrigeration and has a 24 months shelf life at room temperature. The stock drops because it was a share dilution and the shorts profited. The capital rise it was a must. You can check my previous post also. DO YOUR OWN DD AND STOP RELY ON OTHERS.
0 · Reply
bassett
bassett Oct. 27 at 12:32 PM
$SCNX (SCNX) Still red flag. RECT stock of the day i make 27% profit
0 · Reply
Watsonwestie
Watsonwestie Oct. 27 at 12:30 PM
$SCNX lol. See you at 2.00
0 · Reply
JackCampbell
JackCampbell Oct. 27 at 12:27 PM
$SCNX expect exclusive requests and agreements for the distribution of Arbli in other global regions anytime now. Scienture would receive a high upfront payment and percentage of net sales with beginning sales. Further collaborations will enable access to Arbli for patients wordwide in very short time period.
0 · Reply
ChasingGreenCandle
ChasingGreenCandle Oct. 27 at 12:23 PM
$SCNX guys I want to inform you about the following. The share dilution raport: 30/September 21.93 million shares 27/October 34.47 million shares The share dilution was completed. Curent Cash Estimate $14.35 million. So they have cash to operate normaly for a while. They released a new product and the cash will come soon to sustain the business.
1 · Reply
invbond
invbond Oct. 27 at 12:18 PM
$SCNX is holding up well and well above $0.50 level a few days ago. We will be back over to $2.0 again Keep an eye on $VIVK - Squeeze alert ( like SCNX) could pop it back to Friday's high of ~$0.50 and Squeeze it over to $1.X+ Has ~$250M in assets and just closed a $40M CF.
1 · Reply
ChasingGreenCandle
ChasingGreenCandle Oct. 27 at 12:13 PM
$SCNX the share dilution was completed. Algo traded 1.2 million shares in 1 minute from $1.23 to $1.50. If one of this level is breaked we will see the continuation of the stock. I analyze all the move with my python code from time and sales. The only way to see behind the scenes is to fight back with your own tools.
0 · Reply
KryptonianTrader
KryptonianTrader Oct. 27 at 12:08 PM
$SCNX RISE AND PHUCK THE SHORTS…
0 · Reply
Jojomightknow
Jojomightknow Oct. 27 at 12:04 PM
$SCNX share count updated. Diluted from 20.75 to 31.975
1 · Reply
PlayedOutNCruel
PlayedOutNCruel Oct. 27 at 12:01 PM
$SCNX the aliens must be running the show today !!!
1 · Reply
bassett
bassett Oct. 27 at 12:00 PM
$SCNX (SCNX) currently exhibits weak market fundamentals. Profitability ratios are alarmingly negative, with EBIT and EBITDA margins at -15614.4% and -14074.5% respectively, underscoring significant operational inefficiencies. Revenues have seen declines over the 3-year and 5-year periods by -77.63% and -60.18%, a concerning trajectory.a potential red flag for investors.
0 · Reply
igniteyourpassion
igniteyourpassion Oct. 27 at 11:49 AM
$SCNX https://www.timothysykes.com/news/scientureholdingsinc-scnx-news-2025_10_26/
0 · Reply
bassett
bassett Oct. 27 at 11:45 AM
$SCNX Just short squeez Short seller cover their shares, after will drop to 0.8
0 · Reply
grindlife_98
grindlife_98 Oct. 27 at 11:45 AM
$SCNX Banggg🤝🏼🔥
0 · Reply
Limer_814
Limer_814 Oct. 27 at 11:45 AM
$SCNX almost sure the offering is closed already at or above 2.60 last week ..
0 · Reply
Limer_814
Limer_814 Oct. 27 at 11:42 AM
$SCNX Red to Green will be a glorious move
0 · Reply
JackCampbell
JackCampbell Oct. 27 at 11:41 AM
$SCNX ++++BREAKING NEWS++++NOW WITH START OF COMMERCIAL SALES OF ARBLI™+++++ Arbli™ is the first and only oral liquid formulation of losartan approved by the U.S. FDA. Arbli™ comes in a 165 mL bottle as a peppermint flavored suspension that does not require refrigeration and has been approved for a shelf life of 24 months from the date of manufacture when stored at room temperature. BTW: it´s the best in world drug as there is no other liquid formulation approved anywhere!
0 · Reply
TheRealStockRocket
TheRealStockRocket Oct. 27 at 11:10 AM
$RELI If your playing $ASST like me....you need to look at $RELI as well. *See Below. $RELI has a tiny 3M float vs 270M float in $ASST. $ASST has hype & momo... $RELI is going to be a monster low floater play accumulating digital assets from Bitcoin, XRP, Ethereum etc. to coincide with the core business to scale and is strategizing to revolutionize the insurance industry through tokenization. Also there is a .03 per share dividend if you in by Oct. 30 and payble Dec. 2. See 8K i posted earlier. By last 3 calls all did well over 100% with $SCNX doing 350% and $TOVX well over 200%
0 · Reply